Remogliflozin Etabonate + Metformin

Overview

Medicine Type :
Allopathy

Prescription Type:
Prescription Required

Approval :
DCGI (Drugs Controller General of India)

Schedule
Schedule H

Pharmacological Class:

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, Biguanide,

Therapy Class:

Antidiabetic Agent,

Approved Countries

India, the United States, Canada, the United Kingdom, Germany, France and Australia.

References

https://www.torrentian.com/pisheet/Upload/PI_Sheet/3045.pdf
https://www.semanticscholar.org/paper/Remogliflozin-Etabonate
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022352s017lbl.pdf
https://www.medicaid.nv.gov/Downloads/provider/Metformin _2015-1215.pdf

Authored by

Chumbeni

Dr. Chumbeni E Lotha has completed her Bachelor of Pharmacy from RIPANS, Mizoram and Doctor of Pharmacy from SGRRU,Dehradun. She can be reached at editorial@medicaldialogues.in

Reviewed by

Dr JUHI SINGLA

Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751